Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997.
about
Surfactant therapy for bronchiolitis in critically ill infantsBronchodilators for bronchiolitisMonoclonal antibody for reducing the risk of respiratory syncytial virus infection in childrenSurfactant therapy for bronchiolitis in critically ill infantsMonoclonal antibody for reducing the risk of respiratory syncytial virus infection in childrenBronchodilators for bronchiolitisSurfactant therapy for bronchiolitis in critically ill infantsNebulized hypertonic saline solution for acute bronchiolitis in infantsBronchodilators for bronchiolitisNebulized hypertonic saline solution for acute bronchiolitis in childrenEpinephrine for bronchiolitisRespiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoterRespiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiencyPharmacological management of acute bronchiolitisEvidence of a causal role of winter virus infection during infancy in early childhood asthmaRespiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunityUse of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein.Social, economic, and health impact of the respiratory syncytial virus: a systematic searchRecent evidence on the management of bronchiolitisDistinct RIG-I and MDA5 Signaling by RNA Viruses in Innate ImmunityDefining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western CountriesRSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In VivoInnate immunity proteins and a new truncated form of SPLUNC1 in nasopharyngeal aspirates from infants with respiratory syncytial virus infection.Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virusNuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution two-dimensional gel electrophoresisBronchiolitis.Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma.Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants.Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression.Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infectionViral detection using DNA functionalized gold filamentsRecombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.Role of peroxiredoxin 1 and peroxiredoxin 4 in protection of respiratory syncytial virus-induced cysteinyl oxidation of nuclear cytoskeletal proteins.Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice.Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cellsNew insights for development of a safe and protective RSV vaccineGamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragmentRNAi-based therapeutics-current status, challenges and prospectsImmunoprophylaxis of respiratory syncytial virus: global experience.
P2860
Q24187760-DE08EA77-961A-431C-8C5C-F2A3B7F5636FQ24193936-09FB9713-2303-4FDF-B582-9B585D73265BQ24197915-A59BA2B6-5ECA-4851-942A-2AF1BF6453D8Q24200647-63B18243-1D74-4676-AC3C-A962D42F405CQ24234622-6F68108C-AEA5-4D2F-B9C5-23FA7F47D921Q24235615-3015042E-EDD1-4F6D-A7FD-2C85BCC4D0C0Q24236066-6193B62E-7563-4964-9F44-916107B54039Q24241332-0A2BB567-83C5-4D59-BECB-5C3ADFF2D39AQ24245422-6C22C719-2B11-4CA5-9379-D580F04F43F2Q24246001-AF1F6D4E-48D7-4898-8165-A75F1267B004Q24247407-1672B6EA-CA45-4106-B241-45EA3374BE5DQ24296927-096DC527-C037-4785-8517-F17BAE331187Q24646598-786BF40B-BDE7-499C-A2C9-CBCA1DE37D60Q24650574-AA13A2D5-81F0-43EC-BEF8-20930779D042Q24653420-D2DBBDE4-377D-47A6-B338-EE3EBA70D5E8Q24676109-C822AADA-3119-4FBA-BAC2-9F8F16DA341DQ24815873-59187D65-2670-446C-9F82-14E3AA6D247FQ26852865-7A977F24-59B9-48E0-8294-0AB9E9A80B2BQ26998906-7A5BC20D-48D2-4B57-81F9-60586C9EF90DQ27485306-63EA6D26-36C3-43CA-9D85-35725AB54FDDQ28069415-0091226F-F273-4C6D-B39E-DDD09B085361Q28548423-DC05B674-4061-415F-A01C-4F42AE544019Q29871455-03112CB5-84C3-4616-921E-615714EF5C33Q30441455-5A0ED9EC-F59A-4B06-9AC4-60E8721C84B7Q31120475-595EF62E-DB05-4779-B77B-B11E3047CB7CQ33446856-49CB62F1-CB61-48B6-8F09-0A327214F111Q33605739-C7AD6A99-E1E9-4AF6-9E1E-0771BC620D7BQ33723350-7332B235-B803-43F4-92C5-CBF10D28AB9AQ33737766-9B97CF95-1ED4-4CEB-9169-BECC7281AF43Q33781375-9A12B2C2-7F9F-498F-B7C0-608036123659Q33839283-C7D61B65-53A8-4C45-90C1-F74854881FEDQ33840469-D2164E5C-B0E1-42B2-AD14-F548C075571CQ34057989-120B608B-C749-45F4-B4F2-365B0A0527EDQ34120066-D381A8A8-0854-4F49-9DC5-6E6A31691AF8Q34120278-69B6CEE8-0F08-4AA7-B925-1C427FB07245Q34122073-9113554D-CB27-4A37-9F4E-3A8FC8568990Q34249859-74A6C6B9-6F7B-4CCB-AB1E-A8DA9F459F6BQ34347904-DD3C1770-1CB8-4081-B2A3-1E038F5B8676Q34659612-559EB1B7-AEBE-46DF-9670-22ECA0ACB894Q34740842-FD7513BE-A626-4FD3-A452-A69130BB15AB
P2860
Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Bronchiolitis-associated morta ...... among US children, 1979-1997.
@en
Bronchiolitis-associated morta ...... among US children, 1979-1997.
@nl
type
label
Bronchiolitis-associated morta ...... among US children, 1979-1997.
@en
Bronchiolitis-associated morta ...... among US children, 1979-1997.
@nl
prefLabel
Bronchiolitis-associated morta ...... among US children, 1979-1997.
@en
Bronchiolitis-associated morta ...... among US children, 1979-1997.
@nl
P2093
P356
P1476
Bronchiolitis-associated morta ...... among US children, 1979-1997.
@en
P2093
Anderson LJ
Roosevelt GE
P356
10.1086/317655
P407
P577
2000-11-10T00:00:00Z